april
novel
swinederiv
influenza
emerg
spread
rapidli
around
world
caus
world
health
organ
declar
pandem
june
sinc
first
appear
influenza
one
particular
amino
acid
substitut
aspart
acid
glycin
posit
number
within
hemagglutinin
ha
molecul
appear
sporad
countri
includ
norway
mexico
ukrain
usa
substitut
known
caus
shift
receptor
specif
mix
acid
receptor
specif
noteworthi
highli
conserv
among
avian
virus
previous
avian
virus
isol
patient
initi
phase
pandem
avian
ha
human
shown
select
increas
affin
receptor
also
substitut
present
spanish
flu
outbreak
howev
exist
transmiss
influenza
specif
virus
remain
unclear
identifi
whether
specif
virus
replic
well
swine
spread
earli
phase
pandem
whether
specif
virus
easili
transmit
nucleotid
sequenc
ha
receptor
bind
site
influenza
clinic
specimen
determin
studi
attempt
understand
relev
ha
substitut
among
influenza
caus
infect
tunisia
ha
gene
sequenc
respiratori
specimen
sever
nonsever
case
examin
addit
substitut
focus
anoth
substitut
glutam
acid
lysin
acid
mutat
locat
stalk
caviti
fusion
domain
matur
ha
molecul
might
impact
antigen
neutral
activ
influenza
ethic
aspect
studi
approv
charl
nicol
hospit
ethic
committe
pandem
year
total
respiratori
specimen
ili
come
sentinel
physician
network
posit
influenza
pdm
season
case
posit
influenza
report
occurr
amino
acid
substitut
aspart
acid
glycin
posit
ha
subunit
viral
haemagglutinin
clinic
specimen
case
analyz
tunisia
sever
outcom
interestingli
one
fatal
case
four
virus
taken
fatal
case
studi
patient
die
day
suffer
sever
respiratori
symptom
flu
autopsi
reveal
pulmonari
oedema
larg
mucosi
secret
cardiac
inflamm
tabl
also
mutat
found
one
mild
case
mild
case
studi
moreov
found
one
virus
studi
mutat
found
viru
taken
one
patient
sever
clinic
syndrom
sever
case
studi
substitut
found
two
sever
case
analysi
ha
also
show
frequent
substitut
posit
detect
tunisian
virus
studi
genet
analysi
ha
influenza
viru
show
viru
reassort
contain
gene
segment
ancestor
virus
human
swine
avian
sourc
henc
polymorph
posit
within
haemagglutinin
ha
molecul
may
remark
impact
viral
host
rang
replic
pathogen
worth
note
although
mutat
current
associ
sever
pandem
human
associ
sever
initi
propos
kiland
et
al
sinc
differ
studi
sever
countri
found
substitut
frequent
associ
patient
sever
pandem
influenza
nonsever
control
case
recent
studi
support
role
mutat
allow
viru
access
deeper
lung
tissu
hese
unusu
viral
attribut
suggest
new
viru
may
possess
virul
characterist
similar
highli
pathogen
pandem
influenza
virus
studi
use
convent
sequenc
approach
analyz
sampl
obtain
virus
substitut
ha
protein
appear
sporad
spontan
tunisia
sinc
juli
although
found
sever
case
present
studi
substitut
percentag
compar
found
itali
unit
kingdom
franc
spain
lower
publish
norway
hong
kong
differ
norwegian
chines
studi
might
due
reduc
number
sever
case
analyz
countri
tunisia
mutat
observ
circul
viru
obtain
sever
case
also
mild
case
frequenc
substitut
higher
sever
case
mild
case
although
studi
demonstr
presenc
substitut
sever
case
also
report
mild
case
therefor
number
mild
case
would
need
larger
determin
whether
mutant
virus
inde
circul
low
frequenc
also
nonsever
case
ge
polymorph
haemagglutinin
ha
gene
influenza
viru
associ
case
mild
sever
ill
differ
countri
geograph
area
mani
retrospect
analys
found
case
bear
mutat
like
associ
sever
pneumonia
admiss
intens
care
facil
death
major
studi
report
presenc
suffici
enhanc
viru
replic
lethal
mous
model
effect
rang
modest
pronounc
moreov
substitut
present
tunisian
viru
strain
sinc
pandem
season
throughout
season
group
observ
substanti
differ
wildtyp
virus
mous
ferret
model
indic
need
investig
role
virul
influenza
detect
less
frequenc
found
sever
case
patient
despit
avail
virolog
epidemiolog
clinic
inform
substitut
could
confer
sever
diseas
clinic
signific
mutat
still
unclear
studi
demonstr
polymorph
ha
protein
especi
within
receptor
bind
domain
play
critic
role
bind
prefer
pathogen
influenza
viru
studi
warrant
elucid
intrigu
relationship
substitut
sever
diseas
whether
select
mutat
caus
consequ
sever
lower
respiratori
tract
infect
still
resolv
evid
howev
emerg
like
exacerb
sever
diseas
alter
receptor
specif
distinct
cell
tropism
mutant
influenza
hallmark
danger
pathogen
emphas
import
close
monitor
evolut
virus
influenza
variant
ge
polymorph
show
increas
clinic
virul
detect
mutant
next
epidem
mandatori
better
manag
ili
individu
patient
well
surveil
purpos
especi
african
countri
particip
respiratori
sampl
collect
inform
consent
supervis
local
sanitari
author
ha
haemagglutinin
sa
sialic
acid
sa
sialic
acid
ili
influenzalik
ill
none
author
financi
person
conflict
interest
relat
studi
aem
propos
idea
analyz
interpret
data
present
paper
also
wrote
manuscript
fp
jl
particip
data
analysi
interpret
also
revis
manuscript
mtc
ic
revis
manuscript
mhk
revis
manuscript
save
final
approv
version
publish
author
read
approv
final
manuscript
